Skip to main content
Top
Published in: Intensive Care Medicine 8/2011

01-08-2011 | Review

Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit

Authors: Aryeh Shander, Christopher E. Walsh, Caroline Cromwell

Published in: Intensive Care Medicine | Issue 8/2011

Login to get access

Abstract

Objective

There are a number of potential etiologies of severe bleeding encountered in the intensive care unit. Although rare, acquired hemophilia is one such etiology that often presents with major bleeding requiring intensive care. Despite the introduction of effective treatments, the reported mortality rate of patients with acquired hemophilia ranges from 6 to 8% and is in part attributable to sequential delays in diagnosis and appropriate treatment. The purpose of this review is to familiarize the intensive care specialist with this underrecognized cause of bleeding, with an emphasis on diagnosis and treatment.

Methods

As the objective of this article was to provide a concise overview of the diagnosis and management of acquired hemophilia, a directed search of English-language literature was undertaken using the PubMed database, targeting such topics as the differential diagnosis of bleeding in the intensive care unit and the epidemiology, diagnosis, and treatment of acquired hemophilia. Clinical study findings pertaining to the efficacy of specific treatments for acquired hemophilia were summarized.

Results and conclusion

Recognition of acquired hemophilia presents a clinical challenge, given the rarity of this condition, a general lack of familiarity with acquired hemophilia, and the potential for confusion with other more common causes of bleeding in the intensive care unit. Nevertheless, there are sentinel clinical and laboratory findings that should raise suspicion of this diagnosis. The treatment of acquired hemophilia is a multi-step, physiologically focused process aimed at controlling both active and recurrent bleeding. Therefore, prompt diagnosis is central to prognosis. Consultation with a hematologist may facilitate efficient diagnosis and management.
Literature
1.
go back to reference Handin RI (2005) Inherited platelet disorders. Hematology Am Soc Hematol Educ Program 2005:396–402 Handin RI (2005) Inherited platelet disorders. Hematology Am Soc Hematol Educ Program 2005:396–402
2.
go back to reference Hassan AA, Kroll MH (2005) Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program 2005:403–408 Hassan AA, Kroll MH (2005) Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program 2005:403–408
3.
4.
go back to reference Rice TW, Wheeler AP (2009) Coagulopathy in critically ill patients: part 1: platelet disorders. Chest 136:1622–1630PubMedCrossRef Rice TW, Wheeler AP (2009) Coagulopathy in critically ill patients: part 1: platelet disorders. Chest 136:1622–1630PubMedCrossRef
5.
go back to reference Thomas A, Chalmers E (2005) The neonate with hemophilia. In: Lee CA, Berntorp EE, Hoots WK (eds) Textbook of hemophilia, 1st edn. Blackwell Publ, Oxford, pp 125–130CrossRef Thomas A, Chalmers E (2005) The neonate with hemophilia. In: Lee CA, Berntorp EE, Hoots WK (eds) Textbook of hemophilia, 1st edn. Blackwell Publ, Oxford, pp 125–130CrossRef
6.
go back to reference Ogura H, Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group (2007) SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock 28:411–417PubMedCrossRef Ogura H, Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group (2007) SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock 28:411–417PubMedCrossRef
7.
go back to reference Baudo F, de Cataldo F (2008) Acquired hemophilia in the elderly. In: Balducci L, Ershler W, de Gaetano G (eds) Blood disorders in the elderly, 1st edn. Cambridge University Press, Cambridge, pp 387–405 Baudo F, de Cataldo F (2008) Acquired hemophilia in the elderly. In: Balducci L, Ershler W, de Gaetano G (eds) Blood disorders in the elderly, 1st edn. Cambridge University Press, Cambridge, pp 387–405
9.
go back to reference Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 78:1463–1467PubMed Hay CRM, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 78:1463–1467PubMed
10.
go back to reference Morrison AE, Ludlam CA, Kessler C (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 81:1513–1520PubMed Morrison AE, Ludlam CA, Kessler C (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 81:1513–1520PubMed
11.
go back to reference Zeitler H, Ulrich-Merzenich G, Goldmann G, Vidovic N, Brackmann H-H, Oldenburg J (2010) The relevance of the bleeding severity in the treatment of acquired haemophilia––an update of a single-centre experience with 67 patients. Haemophilia 16:95–101PubMedCrossRef Zeitler H, Ulrich-Merzenich G, Goldmann G, Vidovic N, Brackmann H-H, Oldenburg J (2010) The relevance of the bleeding severity in the treatment of acquired haemophilia––an update of a single-centre experience with 67 patients. Haemophilia 16:95–101PubMedCrossRef
12.
go back to reference Tufano A, Coppola A, Guida A, Cimino E, De Gregorio AM, Cerbone AM, Di Minno G (2010) Acquired haemophilia A in the elderly: case reports. Curr Gerontol Geriatr Res 2010:927503. doi:10.1155/2010/927503 PubMed Tufano A, Coppola A, Guida A, Cimino E, De Gregorio AM, Cerbone AM, Di Minno G (2010) Acquired haemophilia A in the elderly: case reports. Curr Gerontol Geriatr Res 2010:927503. doi:10.​1155/​2010/​927503 PubMed
13.
go back to reference Franchini M, Gandini G, Di Paolantonio T, Mariani G (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55–63PubMedCrossRef Franchini M, Gandini G, Di Paolantonio T, Mariani G (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55–63PubMedCrossRef
14.
go back to reference Collins PW, Percy CL (2010) Advances in the understanding of acquired haemophilia A: implications for clinical practice. Br J Haematol 148:183–194PubMedCrossRef Collins PW, Percy CL (2010) Advances in the understanding of acquired haemophilia A: implications for clinical practice. Br J Haematol 148:183–194PubMedCrossRef
15.
go back to reference Huth-Kühne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Levesque H, Mingot Castellano ME, Shima M, St-Louis J (2009) International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 94:566–575PubMedCrossRef Huth-Kühne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Levesque H, Mingot Castellano ME, Shima M, St-Louis J (2009) International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 94:566–575PubMedCrossRef
16.
go back to reference Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121:21–35PubMedCrossRef Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121:21–35PubMedCrossRef
17.
go back to reference Collins P, Baudo F, Huth-Kühne A, Ingerslev J, Kessler CM, Castellano ME, Shima M, St-Louis J, Lévesque H (2010) Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 3:161 Collins P, Baudo F, Huth-Kühne A, Ingerslev J, Kessler CM, Castellano ME, Shima M, St-Louis J, Lévesque H (2010) Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 3:161
18.
go back to reference Harper M, Obolensky L, Roberts P, Mercer M (2007) A case report of acute upper and lower airway obstruction due to retropharyngeal haemorrhage secondary to acquired haemophilia A. Anaesthesia 62:627–630PubMedCrossRef Harper M, Obolensky L, Roberts P, Mercer M (2007) A case report of acute upper and lower airway obstruction due to retropharyngeal haemorrhage secondary to acquired haemophilia A. Anaesthesia 62:627–630PubMedCrossRef
19.
go back to reference Hendricks MV, Hendricks LK, Davis WB (2002) A 54-year-old woman with acute airway obstruction. Chest 122:348–351PubMedCrossRef Hendricks MV, Hendricks LK, Davis WB (2002) A 54-year-old woman with acute airway obstruction. Chest 122:348–351PubMedCrossRef
20.
go back to reference Bonnaud I, Saudeau D, de Toffol B, Autret A (2003) Recurrence of spontaneous subdural haematoma revealing acquired haemophilia. Eur Neurol 49:253–254PubMedCrossRef Bonnaud I, Saudeau D, de Toffol B, Autret A (2003) Recurrence of spontaneous subdural haematoma revealing acquired haemophilia. Eur Neurol 49:253–254PubMedCrossRef
21.
go back to reference Baudo F, Caimi T, de Cataldo F (2010) Diagnosis and treatment of acquired haemophilia. Haemophilia 16:102–106PubMedCrossRef Baudo F, Caimi T, de Cataldo F (2010) Diagnosis and treatment of acquired haemophilia. Haemophilia 16:102–106PubMedCrossRef
22.
23.
go back to reference Wheeler AP, Rice TW (2010) Coagulopathy in critically ill patients: part 2: soluble clotting factors and hemostatic testing. Chest 137:185–194PubMedCrossRef Wheeler AP, Rice TW (2010) Coagulopathy in critically ill patients: part 2: soluble clotting factors and hemostatic testing. Chest 137:185–194PubMedCrossRef
24.
go back to reference Lusher JM (1996) Screening and diagnosis of coagulation disorders. Am J Obstet Gynecol 175:778–783PubMedCrossRef Lusher JM (1996) Screening and diagnosis of coagulation disorders. Am J Obstet Gynecol 175:778–783PubMedCrossRef
25.
go back to reference Collins PW (2003) Management of acquired haemophilia A–more questions than answers. Blood Coagul Fibrinolysis 14:S23–S27PubMedCrossRef Collins PW (2003) Management of acquired haemophilia A–more questions than answers. Blood Coagul Fibrinolysis 14:S23–S27PubMedCrossRef
26.
go back to reference Buczma A, Windyga J (2007) Acquired haemophilia (in Polish). Pol Arch Med Wewn 117:241–245PubMed Buczma A, Windyga J (2007) Acquired haemophilia (in Polish). Pol Arch Med Wewn 117:241–245PubMed
27.
go back to reference Ma AD, Carrizosa D (2006) Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2006:432–437 Ma AD, Carrizosa D (2006) Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2006:432–437
28.
go back to reference Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, Vetter H, Brackmann H-H (2005) Treatment of acquired hemophilia by the Bonn-Malmö protocol: documentation of an in vivo immunomodulating concept. Blood 105:2287–2293PubMedCrossRef Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, Vetter H, Brackmann H-H (2005) Treatment of acquired hemophilia by the Bonn-Malmö protocol: documentation of an in vivo immunomodulating concept. Blood 105:2287–2293PubMedCrossRef
29.
go back to reference Siow BL, Nadarajah K, Jayaratnam FJ (1982) Acquired hemophilia. A case report. Singapore Med J 23:328–330PubMed Siow BL, Nadarajah K, Jayaratnam FJ (1982) Acquired hemophilia. A case report. Singapore Med J 23:328–330PubMed
30.
go back to reference Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM (2000) Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 106:107–116PubMedCrossRef Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM (2000) Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 106:107–116PubMedCrossRef
31.
go back to reference Hoffman M, Monroe DM, Roberts HR (2002) Platelet-dependent action of high-dose factor VIIa. Blood 100:364–365PubMedCrossRef Hoffman M, Monroe DM, Roberts HR (2002) Platelet-dependent action of high-dose factor VIIa. Blood 100:364–365PubMedCrossRef
32.
go back to reference Novo Nordisk A/S (2010) NovoSeven RT Coagulation Factor VIIa (Recombinant) (package insert). Novo Nordisk A/S, Bagsvaerd, Denmark Novo Nordisk A/S (2010) NovoSeven RT Coagulation Factor VIIa (Recombinant) (package insert). Novo Nordisk A/S, Bagsvaerd, Denmark
33.
go back to reference Sumner MJ, Geldziler BD, Pedersen M, Seremetis S (2007) Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 13:451–461PubMedCrossRef Sumner MJ, Geldziler BD, Pedersen M, Seremetis S (2007) Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 13:451–461PubMedCrossRef
34.
go back to reference Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–1800PubMedCrossRef Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–1800PubMedCrossRef
35.
go back to reference Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL, investigators on behalf of the HTRS investigators (2011) Exposure and safety of higher doses of recombinant factor VIIa ≥ 250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008). Haemophilia. doi:10.1111/j.1365-2516.2010.02483.x Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL, investigators on behalf of the HTRS investigators (2011) Exposure and safety of higher doses of recombinant factor VIIa ≥ 250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008). Haemophilia. doi:10.​1111/​j.​1365-2516.​2010.​02483.​x
36.
go back to reference Baxter Healthcare Corporation (2005) FEIBA VH Anti-Inhibitor Coagulant Complex (package insert). Baxter Healthcare Corp, Westlake Village Baxter Healthcare Corporation (2005) FEIBA VH Anti-Inhibitor Coagulant Complex (package insert). Baxter Healthcare Corp, Westlake Village
37.
go back to reference Baxter Healthcare Corporation (2010) FEIBA NF (Anti-Inhibitor Coagulant Complex), Nanofiltered and Vapor Heated (package insert). Baxter Healthcare Corp, Westlake Village Baxter Healthcare Corporation (2010) FEIBA NF (Anti-Inhibitor Coagulant Complex), Nanofiltered and Vapor Heated (package insert). Baxter Healthcare Corp, Westlake Village
38.
go back to reference Sallah S (2004) Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 10:169–173PubMedCrossRef Sallah S (2004) Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 10:169–173PubMedCrossRef
39.
go back to reference Luu H, Ewenstein B (2004) FEIBAR safety profile in multiple modes of clinical and home-therapy application. Haemophilia 10[Suppl 2]:10–16PubMedCrossRef Luu H, Ewenstein B (2004) FEIBAR safety profile in multiple modes of clinical and home-therapy application. Haemophilia 10[Suppl 2]:10–16PubMedCrossRef
40.
go back to reference Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, Berntorp E, Group ftFS (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109:546–551PubMedCrossRef Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, Berntorp E, Group ftFS (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109:546–551PubMedCrossRef
41.
go back to reference Kessler CM (2005) New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program 2005:429–435 Kessler CM (2005) New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program 2005:429–435
42.
go back to reference Berntorp E (2009) Differential response to bypassing agents complicates treatment in patients with haemophilia with inhibitors. Haemophilia 15:3–10PubMedCrossRef Berntorp E (2009) Differential response to bypassing agents complicates treatment in patients with haemophilia with inhibitors. Haemophilia 15:3–10PubMedCrossRef
43.
go back to reference Schneiderman J, Nugent DJ, Young G (2004) Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 10:347–351PubMedCrossRef Schneiderman J, Nugent DJ, Young G (2004) Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 10:347–351PubMedCrossRef
44.
go back to reference Schneiderman J, Rubin E, Nugent DJ, Young G (2007) Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience. Haemophilia 13:244–248PubMedCrossRef Schneiderman J, Rubin E, Nugent DJ, Young G (2007) Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience. Haemophilia 13:244–248PubMedCrossRef
45.
go back to reference Martinowitz U, Livnat T, Zivelin A, Kenet G (2009) Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patient’s with inhibitors. Haemophilia 15:904–910PubMedCrossRef Martinowitz U, Livnat T, Zivelin A, Kenet G (2009) Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patient’s with inhibitors. Haemophilia 15:904–910PubMedCrossRef
46.
go back to reference Kelesidis T, Raphael J, Blanchard E, Parameswaran R (2010) Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep 4:231CrossRef Kelesidis T, Raphael J, Blanchard E, Parameswaran R (2010) Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep 4:231CrossRef
47.
go back to reference Jy W, Gagliano-DeCesare T, Kett DH, Horstman LL, Jimenez JJ, Ruiz-Dayao Z, Santos ES, Ahn YS (2003) Life-threatening bleeding from refractory acquired FVIII inhibitor successfullly treated with rituximab. Acta Haematol 109:206–208PubMedCrossRef Jy W, Gagliano-DeCesare T, Kett DH, Horstman LL, Jimenez JJ, Ruiz-Dayao Z, Santos ES, Ahn YS (2003) Life-threatening bleeding from refractory acquired FVIII inhibitor successfullly treated with rituximab. Acta Haematol 109:206–208PubMedCrossRef
48.
go back to reference Guillet B, Kriaa F, Huysse MG, Proulle V, George C, Tchernia G, D’Oiron R, Laurian Y, Charpentier B, Lambert T, Dreyfus M (2001) Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. Br J Haematol 114:837–844PubMedCrossRef Guillet B, Kriaa F, Huysse MG, Proulle V, George C, Tchernia G, D’Oiron R, Laurian Y, Charpentier B, Lambert T, Dreyfus M (2001) Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. Br J Haematol 114:837–844PubMedCrossRef
49.
go back to reference Green D, Rademaker AW, Briet E (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 70:753–757PubMed Green D, Rademaker AW, Briet E (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 70:753–757PubMed
50.
go back to reference Brack A, Vogeler S, Hilpert J, Berger G, Buhr HJ, Koscielny J (2009) Acquired factor VIII inhibitor. Anesthesiology 111:1151–1154PubMedCrossRef Brack A, Vogeler S, Hilpert J, Berger G, Buhr HJ, Koscielny J (2009) Acquired factor VIII inhibitor. Anesthesiology 111:1151–1154PubMedCrossRef
51.
go back to reference Huth-Kühne A, Lages P, Hampel H, Zimmermann R (2003) Management of severe hemorrhage and inhibitor elimination in acquired hemophilia: the modified Heidelberg–Malmo protocol. Haematologica 88:86–92 Huth-Kühne A, Lages P, Hampel H, Zimmermann R (2003) Management of severe hemorrhage and inhibitor elimination in acquired hemophilia: the modified Heidelberg–Malmo protocol. Haematologica 88:86–92
52.
go back to reference Nemes L, Pitlik E (2000) New protocol for immune tolerance induction in acquired hemophilia. Haematologica 85:64–68PubMed Nemes L, Pitlik E (2000) New protocol for immune tolerance induction in acquired hemophilia. Haematologica 85:64–68PubMed
53.
go back to reference Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CRM (2007) Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 109:1870–1877PubMedCrossRef Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CRM (2007) Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood 109:1870–1877PubMedCrossRef
54.
go back to reference Collins P, Budde U, Rand JH, Federici AB, Kessler CM (2008) Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome. Haemophilia 14:49–55PubMedCrossRef Collins P, Budde U, Rand JH, Federici AB, Kessler CM (2008) Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome. Haemophilia 14:49–55PubMedCrossRef
55.
go back to reference Levy JH, Dutton RP, Hemphill JC III, Shander A, Cooper D, Paidas MJ, Kessler CM, Holcomb JB, Lawson JH (2010) Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 110:354–364PubMedCrossRef Levy JH, Dutton RP, Hemphill JC III, Shander A, Cooper D, Paidas MJ, Kessler CM, Holcomb JB, Lawson JH (2010) Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 110:354–364PubMedCrossRef
56.
go back to reference McGilvray ID, Rotstein OD (2001) Assessment of coagulation in surgical critical care patients. In: Holzheimer RG, Mannick JA (eds) Surgical treatment: evidence-based and problem-oriented. Zuckschwerdt, Munich McGilvray ID, Rotstein OD (2001) Assessment of coagulation in surgical critical care patients. In: Holzheimer RG, Mannick JA (eds) Surgical treatment: evidence-based and problem-oriented. Zuckschwerdt, Munich
57.
58.
go back to reference Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55PubMedCrossRef Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55PubMedCrossRef
59.
go back to reference Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U (2008) Diagnostic workup of patients with accquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 6:569–576PubMedCrossRef Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U (2008) Diagnostic workup of patients with accquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 6:569–576PubMedCrossRef
60.
go back to reference Seegmiller A, Sarode R (2008) Acquired bleeding disorders. In: Irwin RS, Rippe JM (eds) Irwin and Rippe’s intensive care medicine, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1323–1334 Seegmiller A, Sarode R (2008) Acquired bleeding disorders. In: Irwin RS, Rippe JM (eds) Irwin and Rippe’s intensive care medicine, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1323–1334
61.
go back to reference Angstwurm MWA, Dempfle CE, Spannagl M (2006) New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34:314–320PubMedCrossRef Angstwurm MWA, Dempfle CE, Spannagl M (2006) New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34:314–320PubMedCrossRef
Metadata
Title
Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit
Authors
Aryeh Shander
Christopher E. Walsh
Caroline Cromwell
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2258-5

Other articles of this Issue 8/2011

Intensive Care Medicine 8/2011 Go to the issue